This document provides dosing guidelines for various antimicrobials, antifungals, and antivirals used at LPCHS. It notes that doses do not include adjustments for neonates, cystic fibrosis, or renal function. It also states that all inpatient restricted antimicrobial use requires approval from pediatric infectious disease and lists antimicrobials that require such approval. Therapeutic drug monitoring parameters are provided for some agents.